0001144204-14-005054.txt : 20140130 0001144204-14-005054.hdr.sgml : 20140130 20140130172800 ACCESSION NUMBER: 0001144204-14-005054 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140130 DATE AS OF CHANGE: 20140130 EFFECTIVENESS DATE: 20140130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EKSO BIONICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001549084 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-211040 FILM NUMBER: 14561669 BUSINESS ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 510-984-1761 MAIL ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: PN Med Group Inc DATE OF NAME CHANGE: 20120503 D 1 primary_doc.xml X0707 D LIVE 0001549084 EKSO BIONICS HOLDINGS, INC. 1414 HARBOUR WAY SOUTH SUITE 1201 RICHMOND CA CALIFORNIA 94804 510-984-1761 NEVADA PN Med Group, Inc. PN Med Group Inc Corporation true 2012 Nathan Harding 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Executive Officer Director Chief Executive Officer and President Daniel Boren 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Director Frank Moreman 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Executive Officer Chief Operating Officer Russ Angold 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Executive Officer Chief Technology Officer Marilyn Hamilton 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Director Max Scheder-Bieschin 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Executive Officer Chief Financial Officer, Treasurer and Secretary Steven Sherman 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Director Jack Peurach 1414 Harbour Way South Suite 1201 Richmond CA CALIFORNIA 94804 Director Other Technology Decline to Disclose 06b false 2014-01-15 false true true true Units consisting of common stock and warrants to purchase common stock. true The Issuer entered into a definitive merger agreement with Ekso Bionics, Inc. and Ekso Acquisition Corp., dated as of January 15, 2014. 5000 Gottbetter Capital Markets, LLC 20680 EDI Financial, Inc. 15699 488 MADISON AVENUE 12TH FLOOR NEW YORK NY NEW YORK 10022 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA KY KENTUCKY MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MO MISSOURI NJ NEW JERSEY NY NEW YORK OH OHIO OK OKLAHOMA PA PENNSYLVANIA RI RHODE ISLAND SD SOUTH DAKOTA TX TEXAS VT VERMONT WA WASHINGTON WI WISCONSIN false Gottbetter Capital Markets, LLC 20680 Dinosaur Securities LLC 104446 470 PARK AVENUE SOUTH 9TH FLOOR NEW YORK NY NEW YORK 10016 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA KY KENTUCKY MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MO MISSOURI NJ NEW JERSEY NY NEW YORK OH OHIO OK OKLAHOMA PA PENNSYLVANIA RI RHODE ISLAND SD SOUTH DAKOTA TX TEXAS VT VERMONT WA WASHINGTON WI WISCONSIN false 30300000 27436500 2863500 false 200 2243600 0 Cash commissions of 10% of gross proceeds plus warrants to purchase a number of shares of common stock equal to 10% of the number of shares of common stock included in the units sold in the offering. 1900000 Certain proceeds will be used by the Company for general working capital, including compensation expected to be paid to certain executive officers and/or directors who are listed as Related Persons herein over a 24 month period. false EKSO BIONICS HOLDINGS, INC. /s/ Nathan Harding Nathan Harding Chief Executive Officer 2014-01-30